Literature DB >> 10753059

Isolation of monoclonal antibodies directed against the V protein of human parainfluenza virus type 2 and localization of the V protein in virus-infected cells.

M Nishio1, M Tsurudome, M Ito, M Kawano, S Kusagawa, H Komada, Y Ito.   

Abstract

Two monoclonal antibodies (mAbs) specific for the human parainfluenza virus type 2 (hPIV-2) V protein were obtained by immunizing mice with the V protein recombinantly expressed in Escherichia coli. Both mAbs were found to react with the V protein in ELISA and in Western blot analysis. Using these mAbs and previously obtained mAbs specific for hPIV-2 nucleoprotein (NP) or hPIV-2 phospho-(P) protein, we examined the intracellular distributions of the V, P and NP proteins in hPIV-2-infected cells by indirect immunofluorescence analyses. The P and NP proteins were organized in numerous granules in the cytoplasm of hPIV-2 infected cells. In contrast, the V protein showed diffuse nuclear and cytoplasm distributions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10753059     DOI: 10.1007/s004300050108

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  11 in total

1.  Identification of paramyxovirus V protein residues essential for STAT protein degradation and promotion of virus replication.

Authors:  Machiko Nishio; Masato Tsurudome; Morihiro Ito; Dominique Garcin; Daniel Kolakofsky; Yasuhiko Ito
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons.

Authors:  M Nishio; M Tsurudome; M Ito; M Kawano; H Komada; Y Ito
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Recombinant human parainfluenza virus type 2 with mutations in V that permit cellular interferon signaling are not attenuated in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Emerito Amaro-Carambot; Sheila M Nolan; Stephanie Davis; Shenelle-Marie Wise; Caraline Higgins; Konrad Bradley; Olivia Kim; Reina Mayor; Mario H Skiadopoulos; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2010-07-27       Impact factor: 3.616

4.  Identification of RNA-binding regions on the P and V proteins of human parainfluenza virus type 2.

Authors:  Machiko Nishio; Masato Tsurudome; Morihiro Ito; Yasuhiko Ito
Journal:  Med Microbiol Immunol       Date:  2005-08-03       Impact factor: 3.402

5.  Rab27a facilitates human parainfluenza virus type 2 growth by promoting cell surface transport of envelope proteins.

Authors:  Keisuke Ohta; Yusuke Matsumoto; Machiko Nishio
Journal:  Med Microbiol Immunol       Date:  2018-01-27       Impact factor: 3.402

Review 6.  Parainfluenza viruses.

Authors:  Kelly J Henrickson
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

7.  Graf1 Controls the Growth of Human Parainfluenza Virus Type 2 through Inactivation of RhoA Signaling.

Authors:  Keisuke Ohta; Hideo Goto; Yusuke Matsumoto; Natsuko Yumine; Masato Tsurudome; Machiko Nishio
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

8.  Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Margaret A Scull; Emerito Amaro-Carambot; Machiko Nishio; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2009-12-07       Impact factor: 3.616

9.  Expression of human parainfluenza virus type 3 PD protein and intracellular localization in virus infected cells.

Authors:  Greg Wells; Achut Malur
Journal:  Virus Genes       Date:  2008-08-27       Impact factor: 2.198

10.  Enhanced growth of influenza A virus by coinfection with human parainfluenza virus type 2.

Authors:  Hideo Goto; Hironobu Ihira; Keiichi Morishita; Mitsuki Tsuchiya; Keisuke Ohta; Natsuko Yumine; Masato Tsurudome; Machiko Nishio
Journal:  Med Microbiol Immunol       Date:  2015-11-18       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.